Mesoporous silica nanoparticles in drug delivery and biomedical applications.
By Ying Wang, Qinfu Zhao, N. Han, L. Bai, Jia Li, Jia Liu, E. Che, Liang Hu, Qiang Zhang, Tong-ying Jiang and 1 more. Nanomedicine: Nanotechnology, Biology and Medicine, 2015
1,065 citations recorded by the source corpus.
Subfields: Biomaterials, Materials Chemistry, Spectroscopy
View Paper: https://www.semanticscholar.org/paper/2ab54b97724dd280758cfe8841eb7a25afffc924
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Biomaterials
In Materials Chemistry
Citations in the corpus
- Smart nanoparticles for cancer therapy (2023, neutral): “78 Gold nanoparticles .”
- Challenges and Recent Progress in Oral Drug Delivery Systems for Biopharmaceuticals (2019, methodology): “Stimuli-responsivity in this microencapsulation scheme can be implemented through two main approaches: (1) Cleavable covalent bonding/crosslinking between the carrier and the drug in response to stimuli, such as the cleavable bonding at pH values below the plasma pH, and (2) functionalization of the”
- Mesoporous Silica Nanoparticles: A Comprehensive Review on Synthesis and Recent Advances (2018, background): “Several reviews pertaining to MSNs in improving the solubility of the drug [29,30], as controlled/sustained drug delivery system [31], applications in biomedicine [32,33] have been published.”